Not Tagged
nrg oncology
[]
very excited to see the gi005 study team at #gi23 - this ph 2/3 trial evaluating #ctdna as a biomarker for adj chemo benefit in pts w/ low risk stage 2a colon cancer continues to enroll well in us and canada! 
GI Medical Oncologist at MD Anderson |colorectal & anal cancer | Tweets & likes my opinions | Alum @UNC @UTHSC @dukemedicine @MDAndersonNews he/him 🏳️‍🌈